Literature DB >> 21447704

Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling.

Hidehiro Kaneko1, Toshihisa Anzai, Toshiyuki Nagai, Atsushi Anzai, Toshiyuki Takahashi, Yoshinori Mano, Kohkichi Morimoto, Yuichiro Maekawa, Hiroshi Itoh, Tsutomu Yoshikawa, Satoshi Ogawa, Keiichi Fukuda.   

Abstract

AIMS: C-reactive protein (CRP) expression is increased with metabolic alterations. We sought to clarify the effect of CRP on the development of obesity-induced metabolic disorders using human CRP-overexpressing transgenic mice (CRPTG). METHODS AND
RESULTS: CRPTG and their non-transgenic littermates (CON) were fed a standard diet (STD) or a high-fat diet (HFD) from 6 weeks of age. Oral glucose tolerance and intraperitoneal insulin tolerance tests 12 weeks after starting the diets showed deterioration of glucose tolerance and insulin sensitivity in HFD/CRPTG compared with HFD/CON. Hepatocellular ballooning, oil droplets, and peri-sinusoidal fibrosis were more prominent in HFD/CRPTG than in HFD/CON. In HFD/CRPTG, hepatic triglyceride content was higher and serum adiponectin levels lower than in HFD/CON. Epididymal adipose tissue mRNA expression of mucin-like, hormone receptor-like 1, monocyte chemotactic protein-1, and tumour necrosis factor-α in HFD/CRPTG was up-regulated compared with that in HFD/CON. Immunohistochemical staining of epididymal adipose tissue showed that the number of Mac-3(+) macrophages was higher in HFD/CRPTG than in HFD/CON.
CONCLUSION: Human CRP overexpression facilitated the development of insulin resistance and hepatosteatosis with HFD in association with adiponectin down-regulation and enhancement of macrophage infiltration and expression of pro-inflammatory cytokines in epididymal adipose tissue, suggesting its pathogenic role in the development of obesity-induced metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447704     DOI: 10.1093/cvr/cvr088

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  4 in total

1.  C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes.

Authors:  F Liu; H Y Chen; X R Huang; A C K Chung; L Zhou; P Fu; A J Szalai; H Y Lan
Journal:  Diabetologia       Date:  2011-07-09       Impact factor: 10.122

Review 2.  Role of C-Reactive Protein in Diabetic Inflammation.

Authors:  Julijana Stanimirovic; Jelena Radovanovic; Katarina Banjac; Milan Obradovic; Magbubah Essack; Sonja Zafirovic; Zoran Gluvic; Takashi Gojobori; Esma R Isenovic
Journal:  Mediators Inflamm       Date:  2022-05-17       Impact factor: 4.529

3.  C-reactive protein causes insulin resistance in mice through Fcγ receptor IIB-mediated inhibition of skeletal muscle glucose delivery.

Authors:  Keiji Tanigaki; Wanpen Vongpatanasin; Jose A Barrera; Dmitriy N Atochin; Paul L Huang; Ezio Bonvini; Philip W Shaul; Chieko Mineo
Journal:  Diabetes       Date:  2012-10-15       Impact factor: 9.461

4.  C-reactive protein derived from perivascular adipose tissue accelerates injury-induced neointimal hyperplasia.

Authors:  Jia-Yuan Chen; Xiao-Lin Zhu; Wen-Hao Liu; Yong Xie; Hai-Feng Zhang; XiaoQiao Wang; Ru Ying; Zhi-Teng Chen; Mao-Xiong Wu; Qiong Qiu; Jing-Feng Wang; Yang-Xin Chen
Journal:  J Transl Med       Date:  2020-02-11       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.